Sharan S K, Bradley A
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030, USA.
Cancer Surv. 1995;25:143-59.
Transgenic mice expressing various oncogenes have been generated and widely used to study their role in tumorigenesis. The development of targeted mutagenesis allows specific genes to be mutated in mouse embryonic stem cells, which can then be used to generate mice with a germline mutation in that gene. Embryonic stem cell technology has been used to reconstruct genetic lesions in tumour suppressor genes such as p53 and Rb1, originally identified from studies in humans. The tumour susceptibility phenotype of mutant mice has unveiled the tumour suppressor activity of specific genes that were not expected to have such a function. Transgenic and knock out mice will have an increasingly important role in the identification of novel tumour suppressor genes.
已培育出表达各种癌基因的转基因小鼠,并广泛用于研究它们在肿瘤发生中的作用。靶向诱变技术的发展使得特定基因能够在小鼠胚胎干细胞中发生突变,然后可用于培育在该基因中具有种系突变的小鼠。胚胎干细胞技术已被用于重建肿瘤抑制基因(如最初从人类研究中鉴定出的p53和Rb1)中的遗传损伤。突变小鼠的肿瘤易感性表型揭示了原本预计不具有此类功能的特定基因的肿瘤抑制活性。转基因小鼠和基因敲除小鼠在鉴定新的肿瘤抑制基因方面将发挥越来越重要的作用。